Banco Santander, S.A. Moderna, Inc. Transaction History

Banco Santander, S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$135.66 - $197.02 $355,971 - $516,980	-2,624 Reduced 26.46%	7,291 $1.12 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $334,423 - $593,363	-2,825 Reduced 22.17%	9,915 $1.78 Million
Q3 2022 Nov 08, 2022	SELL	$118.07 - $194.18 $4,014 - $6,602	-34 Reduced 0.27%	12,740 $1.51 Million
Q2 2022 Jul 28, 2022	SELL	$117.13 - $176.59 $515,020 - $776,466	-4,397 Reduced 25.61%	12,774 $1.83 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $836,785 - $1.56 Million	-6,617 Reduced 27.82%	17,171 $2.96 Million
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $2.58 Million - $4.21 Million	11,435 Added 92.57%	23,788 $6.04 Million
Q3 2021 Nov 08, 2021	SELL	$221.9 - $484.47 $2.34 Million - $5.1 Million	-10,533 Reduced 46.02%	12,353 $4.75 Million
Q2 2021 Jul 29, 2021	BUY	$129.91 - $234.98 $2.97 Million - $5.38 Million	22,886 New	22,886 $5.38 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Santander, S.A. with notifications on news.